The production of sterile injectable vaccines and other biologics requires complex infrastructure, highly specialized personnel, and robust quality systems.

Vaccines play an essential role in modern healthcare systems. Beyond individual prevention, they are among the most effective tools for reducing the circulation of communicable diseases, protecting vulnerable populations, and lowering the overall public health burden at a population level. In Argentina, public health vaccines are part of a comprehensive strategy that combines scientific evidence, […]

Prevention is one of the most effective tools for protecting a population’s health. In this context, pneumococcal vaccines in Argentina play a central role within immunization strategies, as they help reduce the risk of severe disease—particularly among vulnerable groups—and contribute to lowering hospitalizations and complications. In recent years, public discussion about vaccines has expanded. However, […]

In biopharmaceutical manufacturing, quality does not depend solely on equipment, metrics, or audits.

OSLO/ BUENOS AIRES, 10 DEC—In a milestone for South America, scientists at Argentina’s pharmaceutical company Sinergium Biotech will start preclinical testing of an innovative mRNA vaccine technology that could significantly strengthen regional pandemic preparedness and contain escalating disease outbreaks in their tracks. Backed by a US $1 million investment from CEPI, the exploratory project is […]

When we think about vaccines, we often focus on research and biotechnological production. However, vaccine conditioning and packaging in Argentina

Vaccine production in Latin America is undergoing an unprecedented transformation. With advances in technologies such as mRNA, automation, and applied biotechnology…

The bioindustry is at a turning point. With sustained growth in production, exports and technological capabilities, the country is emerging as a key player in the region.

In January 2025, Sinergium Biotech, in collaboration with Pfizer and the Pan American Health Organization (PAHO), announced the local production of the 20-valent pneumococcal conjugate vaccine (PCV20). This agreement positions Argentina as the first country in Latin America to manufacture this vaccine, strengthening the region’s capacity to address pneumococcal diseases. The goal is to establish […]

Public health has become a strategic priority for countries, and the Latin American pharmaceutical industry is experiencing a challenging time. Demands are higher than ever: increased production capacity, faster turnaround times, cutting-edge technology, regulatory compliance, and, above all, quality and safety assurance in every process. At Sinergium Biotech, as a science-based and internationally certified CMO, […]

Download this guide and discover how to identify a strategic partner, not just a supplier, in the biopharmaceutical world.

Buenos Aires, June 6, 2025. International experts visited the pharmaceutical company Sinergium Biotech to support the development of a vaccine against the influenza A(H5N1) virus based on messenger RNA (mRNA) technology. The meeting is part of the efforts of the World Health Organization (WHO), the Medicines Patent Pool (MPP), and the Pan American Health Organization […]

Pfizer and Sinergium Biotech entered into a collaboration agreement that will allow comprehensive production of the twenty-valent pneumococcal vaccine to begin in the country. It is expected that this private association will allow coverage to be extended nationally and the vaccine exported to the entire region, generating a foreign exchange income for the country of […]

Buenos Aires, January 15, 2025 (PAHO) – The Pan American Health Organization (PAHO), the Government of Argentina, the Pfizer laboratory and the pharmaceutical company Sinergium Biotech announced a joint effort that will facilitate local production and regional access to the 20-valent pneumococcal conjugate vaccine (PCV20). This vaccine will help reduce the burden of pneumococcal diseases, […]

A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries has been launched today. The Argentinian manufacturer Sinergium Biotech will lead this effort leveraging the World Health Organization (WHO) and the Medicines Patent Pool (MPP) mRNA Technology Transfer […]

Meeting of the WHO mRNA Technology Transfer Programme to discuss investment opportunities with multilateral development banks, hosted by PAHO.  Washington, DC – April 17, 2024 – (PAHO)- The Pan American Health Organization (PAHO) hosted a meeting of the WHO mRNA Technology Transfer Programme, with the participation of the fifteen mRNA programme members and major multilateral […]

It was an honor for SINERGIUM Biotech, together with Fernando Lobos to have participated last March 14 in the Dialogue: Opportunities and Challenges for Increasing Vaccine Innovation and Production Capacities in Latin America and the Caribbean, held by Pan American Health Organization. Today I spoke with health technology innovation and production institutions in Latin America […]

Technology transfer and tender won: Sinergium biotech creates a strong alliance with the company Sinovac in order to complete a new technology transfer for the production of the hepatitis A vaccine. The successful introduction of a vaccine into an immunization program is a significant achievement for any country, with vaccines being a fundamental tool in […]

Last Friday we had the honor of receiving Jarbas Barbosa Da Silva Jr, General Director of the Pan American Health Organization and Regional Director for the Americas of the World Health Organization, at our facilities, along with a delegation of PAHO advisors, where signed a new agreement within the program to promote the development and […]

During 24-26 October, we had the privilege of hosting a visit from the Medicines Patent Pool (MPP) as part of the mRNA Technology Transfer Programme. This visit marked a significant step in our ongoing efforts to strengthen our capabilities in the field of mRNA technology. The objectives of this visit encompassed several key areas:Facility Assessment: Our visitors […]

Buenos Aires, October 7, 2023 (PAHO/WHO). The Director of the Pan American Health Organization (PAHO), Jarbas Barbosa, participated yesterday in the closing of the 5th World Summit on Mental Health where he emphasized the importance of integrating this issue into all public policies in order to address social determinants, economic and environmental aspects of mental […]

Buenos Aires, October 3, 2023 (PAHO/WHO) – The Director of the Pan American Health Organization (PAHO), Dr. Jarbas Barbosa, held a meeting today with the President of Argentina, Alberto Fernández, in which they highlighted the need to strengthen the production of vaccines and medical supplies in Latin America and the Caribbean, in order to move […]

Furthermore, as part of the official visit of the PAHO director to Argentina, Vizzotti led a meeting with him together with authorities from ANLIS Malbrán, ANMAT and ANLAP in which they worked on axes prioritized by the national government on health research and development. Within the framework of a high-level meeting with the director of […]

President Alberto Fernández received today the Director of the Pan American Health Organization (PAHO), Jarbas Barbosa, and the Minister of Health, Carla Vizzotti, within the framework of the recent cooperation agreement that Argentina signed with that public health agency to increase vaccine development and production capacities, and two days before the start of the 5th […]

The mRNA technology transfer programme is a global initiative that aims to improve health and health security by establishing sustainable, locally owned mRNA manufacturing capabilities in and for low- and middle-income countries (LMICs).The programme is based around a technology transfer “hub”  Afrigen, which is located in South Africa. They will provide the technology development, training […]

Furthermore, during the 6th G-STIC Conference, the Minister of Health of the Nation referred to the need to consolidate the coordination between the public and private sectors to achieve this objective. The Minister of Health of the Nation, Carla Vizzotti, participated today in the panel “Vaccine Production in Developing Countries”, organized by G-STIC, the global […]

The special distinctions are dedicated to the strengthening of SMEs, tourism, contribution to health and animal welfare certification. The 2023 Fortuna Award for Contribution to Public Health was awarded to Sinergium Biotech. Its CEO, Alejandro Gil, received the award from Martín Cabrales, vice president of Cabrales. “The motto of our company is ‘We take care […]

The representatives of the organization did so together with directors of the Pan American Health Organization. They met with national authorities and with the team that is carrying out the technology transfer process for said production. The World Health Organization (WHO) announced in 2021 the creation of a technology transfer center, Afrigen, located in South […]

Buenos Aires, February 15, 2023 (PAHO) — A mission of delegates from the Pan American Health Organization (PAHO), the World Health Organization (WHO), and the Medicines Patent Pool visited Argentina and met with authorities national health agencies and the biopharmaceutical company Sinergium Biotech in order to continue advancing technological transfer for the production of messenger […]